UK Markets closed
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • FTSE 250

    18,109.57
    +215.15 (+1.20%)
     
  • AIM

    980.45
    +11.44 (+1.18%)
     
  • GBP/EUR

    1.0988
    -0.0074 (-0.67%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.3207%)
     
  • BTC-GBP

    10,010.60
    +123.04 (+1.24%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • DOW

    28,335.57
    -28.09 (-0.10%)
     
  • CRUDE OIL

    39.78
    -0.86 (-2.12%)
     
  • GOLD FUTURES

    1,903.40
    -1.20 (-0.06%)
     
  • NIKKEI 225

    23,516.59
    +42.32 (+0.18%)
     
  • HANG SENG

    24,918.78
    +132.65 (+0.54%)
     
  • DAX

    12,645.75
    +102.69 (+0.82%)
     
  • CAC 40

    4,909.64
    +58.26 (+1.20%)
     

Vitalograph Launch Powerful New In2itive e-Diary for Global Clinical Trials

Vitalograph
·1-min read


Next generation eCOA device with integrated respiratory assessment

Vitalograph are delighted to announce that their most powerful ever In2itive e-Diary is now available for global clinical trials, offering the ideal solution for respiratory endpoint studies.

The new In2itiveTM e-Diary is a robust handheld medical device with touchscreen for eCOA data gathering.
Using Vitalograph’s proven Fleisch Pneumotachograph flowhead, it provides accurate measurement of respiratory endpoints in clinic or for home monitoring.

Features

  • Easy to use with large, high resolution, responsive touch screen.

  • Live spirometry feedback promotes high quality, reliable data.

  • Integrated training modules provide technique reminders supporting compliance and data quality.

  • Alerts, reminders, and workflows are fully customizable to fit study protocols.

  • Pre validated for a range of e-PROs to cover respiratory endpoints and health status.

  • Date/time stamps ensuring data integrity.

  • Secure end-to-end encrypted data transmission.

Fully integrated wireless communications (cellular/mobile) allow automatic secure transmission of data to the study web portal. Uploaded data is available for instant review, giving remote insight into site
and subject performance. The In2itive e-Diary is a fully validated class II (USA) / IIa (EU) medical device, meeting or exceeding all technical requirements for cyber-security and data protection.

The new device meets the performance requirements of ISO 23747 (peak flow), ISO 26782 (volumes) and adheres to guidance in the ATS/ERS joint 2019 technical statement on the standardization of spirometry.

About Vitalograph

Vitalograph is a global leader in respiratory diagnostic devices, clinical trial services and medical equipment servicing.
With a pioneering heritage of excellence spanning half a century, Vitalograph continues to make valuable contributions to effective medical care and enhanced quality of life.

Watch the In2itive e-Diary video here

Press contact | Helen Venn | helen.venn@vitalograph.co.uk

Attachment